Background {#Sec1}
==========

Human sperm cryopreservation is an important technique for infertility management in human reproductive medicine and for male fertility preservation in cases of malignancy treatments \[[@CR1], [@CR2]\]. However, current sperm freezing protocols are not optimal and the freezing and thawing process results in inevitable changes, both at structural and molecular levels, most of them are detrimental to sperm and therefore, cryopreserved sperm have shown decreased frozen-thawed motility, cell viability and fertilizing ability compared to fresh sperm \[[@CR3]\]. It has been proven that physical and chemical factors including rapid change in temperature, intracellular ice formation, osmolality increase, oxidative stress, pH change, and adenosine triphosphate (ATP) production disturbance are the main causes of sperm cryoinjuries during the freezing and thawing process \[[@CR4]--[@CR12]\]. However, the mechanism of sperm cryoinjury remains unclear.

Previous studies have indicated that the freezing--thawing process results in loss of sperm plasma membrane proteins, changes in sperm membrane composition, and deleterious effects on sperm plasma membrane integrity \[[@CR13]--[@CR15]\]. The plasma membrane disruption leads to leakage of intracellular sperm proteins and the loss of cytoplasmic proteins, membrane-bound proteins, enzymes and other cellular components. Sperm proteins are responsible for sperm function \[[@CR16]\]. The loss of sperm proteins may negatively affect fertilization and early embryonic development, and result in male infertility \[[@CR17]\]. A promising approach to identify extensive proteins affected by cryopreservation is to investigate the proteomic profile of sperm before and after freezing and thawing. The monitoring of proteinic alteration at the proteomics level in human sperm will benefit our understanding of the mechanism of cryoinjuries resulted from the sperm freezing and thawing process. Proteomics is a powerful tool for discovery of differentially expressed proteins \[[@CR18], [@CR19]\]. It has been applied to characterize changes in sperm proteins under various conditions including cryopreservation. Two dimensional gel electrophoresis has been used to detect the proteome of sperm \[[@CR20]\]. Recently, the development of liquid chromatography and mass spectrometry has allowed the analysis of proteomes with higher practical throughput strategies. The method used for the quantification of proteins has developed into a combination of isobaric tags for relative and absolute quantification (iTRAQ) and LC--MS/MS \[[@CR21]\].

Commercially available egg-yolk free media have been developed and widely used for human sperm freezing \[[@CR22]\]. In contrast to conventional egg yolk media, these commercial media contain only chemically defined components, which avoid the potential contamination with animal origin of bacteria, fungi, viruses, and prions, and eliminate the risk of sperm damage by the endotoxins produced by microbes in egg yolk \[[@CR23]\]. However, in general, sperm cryopreserved with a chemically defined medium either by using computerized slow-stage freezing or nitrogen vapor fast freezing showed compromised frozen-thawed sperm motility and vitality compared to those cryopreserved with a conventional egg yolk medium \[[@CR23], [@CR24]\]. Therefore, cryodamage is still a general and unavoidable phenomenon and an established universal method that can be referred to as an entrenched standard for routine laboratory use is still needed \[[@CR24]\]. The progress in proteomics provides a promising method to identify key proteins of sperm that are affected by cryopreservation and explore the mechanism of cryoinjuries which lead to the decline of sperm function and fertilizing ability. A few studies have reported qualitative changes of protein profiles in fish, boar, rat, chicken, ram and human sperm \[[@CR25]--[@CR30]\]. Conventionally, cryostraws (CS) and cryovials (CV) are the most widely used cryopreservation carriers (CPCs) for human sperm cryopreservation accompanied with the use of commercial egg yolk-free media. However, the influence of cryopreservation on the proteomic profile of human sperm preserved with the two CPCs is still unknown.

Therefore, the aims of this study were to (1) compare two different CPCs: cryostraw (CS) and cryovial (CV) on the cryosurvival of human sperm frozen with a chemically defined medium, (2) investigate the proteomic profiles of human sperm cryopreserved with CS and CV, which were evaluated by using iTRAQ techniques, and (3) identify the susceptible proteins that play key roles in sperm function and fertility. Our study will be beneficial for extending the knowledge of cryoinjuries and will provide fundamental information for the development and optimization of human sperm cryopreservation methods.

Methods {#Sec2}
=======

Ethics statement {#Sec3}
----------------

The protocol of the present study was approved in advance by the Ethics Review Board of Kunming University of Science and Technology and Kunming Sino-UK Angel Women's & Children's Hospital. Informed consent for participation was obtained from all subjects.

Semen collection and assessment {#Sec4}
-------------------------------

Semen samples were obtained from a total of 11 healthy male volunteers aged from 26 to 49 years after 7 days of sexual abstinence. All semen samples were collected by masturbation into a sterile container. The semen was allowed to liquefy at 37 °C for at least 30 min, then a routine semen analysis was performed to determine semen volume, sperm concentration, motility, and morphology according to 5th edition of the World Health Organization (WHO) manual (2010). Only the semen samples that met the following criteria: volume ≥ 2.0 mL, sperm concentration ≥ 40 × 10^6^/mL, and progressive motility ≥ 50% were used in this study \[[@CR31]\].

Cryopreservation and thawing of sperm samples {#Sec5}
---------------------------------------------

Each completely liquefied semen sample was divided into three aliquots that were referred to as control group (C), cryostraw group (CS) and cryovial group (CV). Semen samples of CS and CV were cryopreserved with Vitrolife's SpermFreeze Solution (Vitrolife, Sweden) by following the manufacturer's instructions. Briefly, an equal volume of Vitrolife's SpermFreeze Solutions were added slowly and dropwise to the semen samples of CS and CV group, and then carefully mixed. The mixtures were equilibrated at room temperature for 10 min and were then sealed into pre-cooled (4 °C) 0.25 ml cryostraws (IMV, L'Aigle, France) (CS group) or 1 ml cryovials (Thermo, USA) (CV group). The cryostraws and cryovials were horizontally and uprightly placed on a Styrofoam board with a 2 cm thickness in a liquid nitrogen bath, respectively. After being held in the liquid nitrogen vapor for 30 min, the semen samples were submerged directly into liquid nitrogen. After a minimum of 7 days of storage in liquid nitrogen, the cryostraw and cryovials were thawed by being plunged directly into a 37 °C water bath for 30 s and 10 min, respectively. Then the post-thaw parameters of motilities were checked.

Determination of the motility parameters {#Sec6}
----------------------------------------

The motility parameters of fresh sperm (C) and frozen-thawed sperm from CS and CV groups were examined with a computer assisted sperm analyzer (CASA, Sperm Class Analyzer Microptic, Barcelona, Spain) \[[@CR23]\]. Each specimen was randomly sampled with at least 600 sperm and the kinetic parameters were evaluated within 5 min with the CASA. The descriptors of sperm motility included percentage of motile sperm (MOT), forward activity rate (FAR), curvilinear velocity (VCL), straight line velocity (VSL), average path velocity (VAP), linearity(LIN), straightness index (STR), vibration index (VIB) and amplitude of lateral head displacement (ALH).

Extraction of sperm proteins {#Sec7}
----------------------------

The semen samples from C, CS, and CV groups were washed 3 times with PBS at 500 g for 10 min. The proteins of sperm collected from the three groups were extracted by the trichloroacetic acid (TCA)/acetone precipitation method. The samples were placed in a mortar and pulverized by addition of liquid nitrogen. Then the powder was placed in a 50 ml centrifuge tube with 10% pre-cooled TCA-acetone solution (containing 0.1% DTT and 1 m M PMSF) at 4 °C overnight. The solution was centrifuged at 12,000*g* for 20 min at 4 °C, and then the supernatant was discarded. The precipitate was re-suspended in the acetone (containing 0.1% DTT and 1 mM PMSF) and was allowed to stand at − 20 °C for 2 h. The solution was centrifuged at 12,000*g* for 20 min at 4 °C again. The precipitate was dried in a freeze-dried vacuum dryer for 30 min. The dry protein powder was stored in a refrigerator at − 80 °C.

iTRAQ labeling {#Sec8}
--------------

Each sample contained 100 μg of protein with 5 times the volume of pre-cooled acetone and was at − 20 °C for 1 h. The solution was centrifuged for 20 min at 12,000*g*/min at 4 °C and the supernatant was discarded. The precipitate was then vacuum freeze-dried. After the addition of 50 μL of the Dissolution Buffer in the iTRAQ kit, the samples were mixed thoroughly with a vortex mixer, 4 μL of the Reducing Reagent was added, and the samples were placed at 60 °C for 1 h. Then, 2 μL of Cysteine-Blocking Reagent was added for 10 min at room temperature. The protein solution after each reductive alkylation was pipetted into an ultrafiltration tube (Nanosep MF Centrifugal concentrator). The samples were centrifuged for 40 min at 12,000*g* at 4 °C and the supernatant was discarded. After the addition of 100 μL of the Dissolution Buffer, the samples were centrifuged for 30 min at 12,000*g*. Trypsin (concentration 1 μg/μL) was added to each sample and hydrolyzed at 37 °C for 14 h. After centrifugation (4 °C, 12,000*g*, 40 min), 50 μL of the Dissolution Buffer was added to the ultrafiltration tube and then centrifuged again (4 °C, 12,000*g*, 30 min). The corresponding iTRAQ marker was added to the sample according to the correspondence between the sample and the marker, and the mixture was centrifuged thoroughly and allowed to stand at room temperature for 2 h. Mass spectrometry was performed using the TripleTOF5600 system (SCIEX) combined with the lift-off spray III ion source (SCIEX, USA).

Selection of the differential proteins {#Sec9}
--------------------------------------

The experimental data were analyzed using Protein Pilot Software v. 5.0 (SCIEX, USA). The standard for confidently identifying a protein is if the protein meets the following; a FDR (false discovery rate) \< 1%, Unused \> 1.3, and peptides (95%) ≧1. Differential protein screening was based on a trusted protein. The ratio between the samples were at 1.3-fold change (increased) or less than 1/1.3-fold change (decreased) (p \< 0.05) and the trend was consistent. Through the comparison of the two experimental groups, we obtained three sets of differential protein spectra, including Cryostraw/Control (CS/C), Cryovial/Control (CV/C), and Cryovial/Cryostraw (CV/CS). UniProtKB database ([www.uniprot.org](http://www.uniprot.org)) was used to categorize proteins which were enriched. The official gene symbols of the differentially expressed proteins were used to investigate and categorize the GO annotations. The original GO annotations (cellular components, molecular functions, and biological processes) were downloaded from the NCBI Entrez Gene database and the proteins related to sperm function were selected after further analysis.

Statistical analysis and bioinformatics analysis {#Sec10}
------------------------------------------------

The motility parameters of sperm (MOT, FAR, VCL, VSL, VAP, LIN, STR, VIB and ALH) scored by CASA are presented as mean ± SD. The percentage data for sperm motility underwent arcsine square root transformation before statistical analysis. ANOVA and the Fisher protected least-significant difference test (SPSS 16, SPSS, Chicago, IL) were used to analyze differences among control, CS, and CV groups. A *p* value of less than 0.05 was considered to be statistically significant.

Gene Ontology (GO) enrichment analysis of differentially expressed genes was implemented by GOseq, in which gene length bias was corrected. GO functional analyses provided GO functional classification annotation for DEGs as well as GO functional enrichment analysis for DEGs. GO was generated using the Gene Ontology database (<http://www.geneontology.org/>). Different genes usually cooperate with each other to exercise their biological functions. Pathway-based analysis helps to further understand these genes biological functions. KEGG is the major public pathway-related database (<http://www.genome.jp/kegg/>). KOBAS software was used to test the statistical enrichment of differential expression genes in KEGG pathways (*p* value \< 0.05).

Results {#Sec11}
=======

Effect of cryopreservation on the motility parameters of human sperm frozen in cryostraw and cryovial {#Sec12}
-----------------------------------------------------------------------------------------------------

The motility parameters of human sperm cryopreserved with Vitrolife's SpermFreeze Solution in cryostraws and cryovials were summarized in Table [1](#Tab1){ref-type="table"}. Compared to fresh control, sperm cryopreserved in either cryostraws or cryovials showed significant decrease in the percentage of MOT, the rate of FAR and the velocity of VCL, VSL and VAP (*p *\< 0.05), and significant differences of MOT and FAR were observed between sperm from CS and CV groups (*p *\< 0.05). However, the velocity of VCL, VSL and VAP did not differ between the CS and CV groups (*p *\> 0.05). In addition, the percentage of LIN, STR and VIB did not differ among the 3 groups (*p *\> 0.05).Table 1Effect of cryopreservation on the motility parameters of human sperm frozen in cryostraw and cryovialGroupControl (C)Cryostraw (CS)Cryovial (CV)p valueC:CSC:CVCS:CVMOT (%)81.83 ± 5.71^a^19.10 ± 4.67^b^27.55 ± 9.60^c^9.37E−183.55E−160.01FAR (%)63.36 ± 7.65^a^9.72 ± 3.43^b^15.48 ± 6.17^c^1.06E−171.85E−160.04VCL (μm/s)39.26 ± 6.26^a^27.69 ± 3.98^b^27.78 ± 2.73^b^5.11E−065.75E−060.97VSL (μm/s)14.49 ± 2.93^a^9.31 ± 1.75^b^9.64 ± 1.87^b^2.00E−054.83E−050.75VAP (μm/s)23.95 ± 3.43^a^16.19 ± 2.18^b^16.29 ± 2.13^b^5.07E−076.31E−070.93LIN (%)37.13 ± 5.4533.62 ± 4.2234.49 ± 4.130.100.210.68STR (%)60.33 ± 5.6257.27 ± 6.6358.77 ± 4.870.240.550.56VIB (%)61.31 ± 3.9958.78 ± 4.6758.59 ± 3.830.190.160.92ALH (μm)2.09 ± 0.31^a^1.89 ± 0.28^ab^1.82 ± 0.14^b^0.090.030.54Different superscripts within a row indicate significant differences (*p* \< 0.05)*MOT* motile sperm; *FAR* forward activity rate; *VCL* curvilinear velocity; *VSL* straight line velocity; *VAP* average path velocity; *LIN* linearity; *STR* straightness index; *VIB* vibration index; *ALH* amplitude of lateral head displacement

Identification of human sperm proteins {#Sec13}
--------------------------------------

A total of 3294 proteins were identified in human sperm (Additional file [1](#MOESM1){ref-type="media"}: Table S1). False Discovery Rates (FDRs) using a reverse concatenated decoy database resulted in estimates of peptide and protein FDR to be smaller than 1%. The differentially identified human sperm proteins among control, CS, and CV are summarized in Fig. [1](#Fig1){ref-type="fig"} and Additional file [2](#MOESM2){ref-type="media"}: Table S2. The results showed that after freezing and thawing, the sperm cryopreserved with either cryostraw or cryovial (CS or CV group) presented a large number of changes in sperm proteins compared to those from the non-frozen control group (C group). The results showed that 115 proteins increased and 317 proteins decreased between CS and control (Fig. [1](#Fig1){ref-type="fig"}a), 139 proteins increased and 295 proteins decreased between CV and control (Fig. [1](#Fig1){ref-type="fig"}b), and 11 proteins increased and 32 proteins decreased between CS and CV (Fig. [1](#Fig1){ref-type="fig"}c). According to the Venn diagram analysis of sperm proteomic profile shown in Fig. [1](#Fig1){ref-type="fig"}d, a total of 584 identified proteins were differentially distributed among the human sperm from the C, CS and CV groups, and 9 proteins were differentially present in the three groups simultaneously and presented an intersection among the three groups.Fig. 1Identification of human sperm differential proteins. Differentially identified human sperm proteins between cryostraw and control (**a**), between cryovial and control (**b**), and between cryovial and cryostraw (**c**) were quantified. The red and green bars represent increased protein and decreased protein, respectively. Venn diagrams show the differences in differentially identified human sperm proteins among the three groups (**d**)

Gene ontology (GO) functional analysis {#Sec14}
--------------------------------------

The enrichment analysis of Gene Ontology (GO) and the cellular localizations of the identified differential proteins between the C, CS, and CV groups are presented in Fig. [2](#Fig2){ref-type="fig"}.Fig. 2Biological process and cellular localization. Biological process of differential protein, cryostraw/control (**a**) cryovial/control (**c**) and cryovial/cryostraw (**e**). The Differential protein were examined with respect to cellular localization using GO annotation analysis, cryostraw/control (**b**) cryovial/control (**d**) and cryovial/cryostraw (**f**)

The distribution of biological processes in the ontology of GO terms between C and CS groups were mostly presented in the metabolic processes category, which included small molecule metabolic process (72 proteins, p = 2.09E−36, GO:0044281), organonitrogen compound metabolic process (12 proteins, p = 3.19E−33, GO:1901564), protein metabolic process (64 proteins, p = 2.45E−24, GO:0019538), carbohydrate derivative metabolic process (1 proteins, p = 1.45E−12, GO:1901135), primary metabolic process (3 proteins, p = 1.78E−12, GO:0044238), single-organism metabolic process (9 proteins, p = 6.79E−22, GO:0044710, and other metabolic processes (8 proteins, p = 8.39E−08, GO:0008152). In addition, the distribution of biological terms in the ontology of GO terms were also enriched in proteins that involved in particular cellular processes, including multi-organism process (110 proteins, p = 2.01E−45, GO:0051704), reproduction (1 proteins, p = 1.66E−25, GO:0000003), regulation of response to stress (1 proteins, p = 4.01E−21, GO:0080134), response to stress (9 proteins, p = 1.15E−18, GO:0006950), and cytoplasmic transport (1 proteins, p = 6.14E−10, GO:0016482) (Fig. [2](#Fig2){ref-type="fig"}a).

The statistical analysis of functional over-representation showed that the cellular localizations of the identified differential proteins between the C and CS groups are enriched in the extracellular membrane-bounded organelle (184 proteins, p = 1.94E−106, GO:0065010), cytosol (41 proteins, p = 1.39E−53, GO:0005829), and cytoplasm (81 proteins, p = 1.39E−51, GO:0005737) (Fig. [2](#Fig2){ref-type="fig"}b).

Similarly, the distribution of biological processes in the ontology of GO terms between C and CV groups were mostly presented in the metabolic processes category, which included small molecule metabolic process (69 proteins, p = 1.14E−34, GO:0044281), organonitrogen compound metabolic process (9 proteins, p = 4.71E−28, GO:1901564), protein metabolic process (32 proteins, p = 2.00E−17, GO:0019538), single-organism metabolic process (7 proteins, p = 2.40E−17, GO:0044710), primary metabolic process (11 proteins, p = 8.57E−12, GO:0044238) and other metabolic processes (5 proteins, p = 6.01E−07, GO:0008152). In addition, the distribution of biological terms in the ontology of GO terms were also enriched in proteins that involved in multi-organism process (101 proteins, p = 8.20E−42, GO:0051704), organic substance catabolic process (13 proteins, p = 1.26E−24, GO:1901575), stimulatory C-type lectin receptor signaling pathway (2 proteins, p = 1.25E−23, GO:0002223), reproduction (1 proteins, p = 4.12E−23, GO:0000003), positive regulation of canonical Wnt signaling pathway (1proteins, p = 3.12E−18, GO:0090263), protein folding (8 proteins, p = 7.65E−18; GO:0006457), response to stress (10 proteins, p = 5.19E−16, GO:0006950), negative regulation of biological process (9 proteins, p = 3.05E−13, GO:0048519) and cellular component organization (12 proteins, p = 7.62E−11, GO:0016043) (Fig. [2](#Fig2){ref-type="fig"}c).

The statistical analysis of functional over-representation showed that the cellular localizations of the identified differential proteins between the C and CV groups were enriched in extracellular membrane-bounded organelle (170 proteins, p = 1.27E−96, GO:0065010), cytosol (40 proteins, p = 1.09E−52, GO:0005829) and cytoplasm (71 proteins, p = 1.25E−41; GO:0005737) (Fig. [2](#Fig2){ref-type="fig"}d).

The distribution of biological processes in the ontology of GO terms between CS and CV groups included respiratory electron transport chain (7 proteins, p = 5.32E−11, GO:0022904), energy derivation by oxidation of organic compounds (1 proteins, p = 4.16E−09, GO:0015980), organophosphate metabolic process (5 proteins, p = 1.48E−08, GO:0019637), small molecule metabolic process (1 proteins, p = 7.02E−07, GO:0044281), organonitrogen compound metabolic process (2 proteins, p = 2.67E−05, GO:1901564), oxidation--reduction process (1 proteins, p = 8.06E−05, GO:0055114), cellular transition metal ion homeostasis (3 proteins, p = 2.32E−04, GO:0046916), phosphate - containing compound metabolic process (1 proteins, p = 3.90E−04, GO:0006796), ion transport (2 proteins, p = 7.48E−04, GO:0006811), multi-organism process (2 proteins, p = 1.27E−03, GO:0051704), single-organism cellular process (5 proteins, p = 1.41E−03, GO:0044763), chaperone-mediated protein folding (1 proteins, p = 2.78E−03, GO:0061077), positive regulation of proteolysis (1 proteins, p = 5.95E−03, GO:0045862), and cellular process (1 proteins, p = 1.80E−02, GO:0009987) (Fig. [2](#Fig2){ref-type="fig"}e).

The statistical analysis of functional over-representation showed that the cellular localizations of the identified differential proteins between the CS and CV groups were enriched in extracellular membrane-bounded organelle (16 proteins, p = 1.85E−09; GO:0065010) and cytoplasm (15 proteins, p = 2.06E−07; GO:0005737) (Fig. [2](#Fig2){ref-type="fig"}f).

In order to further analyze the effect of cryopreservation on human sperm function, 106 differential proteins having known identities in sperm functions, according to the UniProtKB database, were identified. The functions of these differentially sperm proteins are listed in Table [2](#Tab2){ref-type="table"}, which are associated with spermatogenesis, iron ion binding, spermatid development, binding of sperm to zona pellucida, sperm capacitation or acrosome reactions, flagellated sperm motility, flagellar microtubules, serine-type endopeptidase inhibitor activity, serine-type peptidase activity and mitochondrial. Specific protein information and the fold of change in different groups were shown in Table [3](#Tab3){ref-type="table"}.Table 2Biological processes classification of differential identified proteins with known identities of sperm functionsBiological processesGene name (Accession)Iron ion bindingARSA (P15289), CABYR (O7592), CALR (P27797),CRISP2 (P16562), DPEP3 (Q9H4B8), FKBP1A (P62942),HSP90B1 (P14625), HSPA5 (P11021), NDUFS3 (O75489),PHGDH (O43175), RDH16 (O75452), SEMG1 (P04279),VAT1 (Q99536)SpermatogenesisACE (P12821), ACSBG2 (Q5FVE4), ACTR1A (P61163),CCDC136 (Q96JN2-4), CYLC2 (Q14093), HSF2BP (O75031),HSPA2 (P54652), KRT9 (P35527), MNS1 (Q8NEH6),NUP62 (P37198), OAZ3 (Q9UMX2), PAFAH1B3 (Q15102),PGAM2 (P15259), PRDX4 (Q13162), PSMA1 (P25786),PSMA2 (P25787), PSMA3 (P25788), PSMA4 (P25789),PSMA5 (P28066), PSMB1 (P20618), PSMB4 (P28070),PSMB5 (P28074), PSMB7 (Q99436), RAD23B (P54727),ROPN1B (Q9BZX4), RUVBL1 (Q9Y265), SMRP1 (Q8NCR6),SOD1 (P00441), SPA17 (Q15506), SPANXA1 (Q9NS26),SPATA6 (Q9NWH7), SPEM1 (Q8N4L4), TXNDC2 (Q86VQ3)Spermatid developmentDPY19L2 (Q6NUT2), FSCN3 (Q9NQT6), KLHL10 (Q6JEL2),SPAG6 (O75602-3), SPANXB1 (Q9NS25)Binding of sperm to zona pellucidaZPBP1 (Q9BS86), ZPBP2 (Q6X784)Flagellated sperm motilityCCDC147 (Q5T655), DNALI1 (O14645), DPCD (Q9BVM2),LDHC (P07864), PGK2 (P07205), SMCP (P49901)Flagellar microtubulesTEKT1 (Q969V4), TEKT2 (Q9UIF3), TEKT3 (Q9BXF9),TEKT4 (Q8WW24), TEKT5 (Q96M29)Serine-type endopeptidase inhibitor activitySLPI (P03973), SPINT3 (P49223), WFDC8 (Q8IUA0)Serine-type peptidase activityCTSG (P08311), PPP4R1 (Q8TF05), PREP (P48147),PRSS37 (A4D1T9), PRTN3 (U3KPS2)Sperm capacitation or acrosome reactionsACR (P10323), ACRBP (Q8NEB7), AKAP3 (O75969),BSPH1 (Q075Z2), C9orf9 (Q96E40), ELSPBP1 (Q96BH3),PRKACA (P17612), SEPT4 (O43236), TCP11 (Q8WWU5)MitochondrialATP5D (P30049), ATP5H (O75947), ATP5 J (P18859),C21orf33 (P30042), COX4I1 (P13073), COX5B (P10606),COX6B1 (P14854), CYCS (C9JFR7), FSIP2 (Q5CZC0),IMMT (Q16891-4), MPC1L (P0DKB6), MRPS36 (P82909),NDUFA4 (O00483), PHB2 (J3KPX7), VAT1 (Q99536),VDAC3 (Q9Y277)OtherCCDC108 (Q6ZU64), GNPDA1 (P46926), MRPS36 (P82909),NAMPT (P43490), PATE1 (Q8WXA2), PATE4 (P0C8F1),PGK1 (P00558), PMFBP1 (Q8TBY8-2), SEPHS1 (P49903),STOM (P27105), TSGA10 (Q9BZW7) Table 3106 differential proteins associated with sperm functionProtein IDProtein nameCS/CCV/CCV/CSACEAngiotensin-converting enzyme0.590.48N/AACRAcrosin0.320.39N/AACRBPAcrosin-binding proteinN/A0.49N/AACSBG2Long-chain-fatty-acid--CoA ligase ACSBG20.460.54N/AACTR1AAlpha-centractin0.270.18N/AAKAP3A-kinase anchor protein 34.073.56N/AARSAArylsulfatase A0.480.48N/AATP5DATP synthase subunit delta, mitochondrialN/A1.68N/AATP5HATP synthase subunit d, mitochondrial2.58N/A0.82ATP5 JATP synthase-coupling factor 6, mitochondrial1.941.50N/ABSPH1Binder of sperm protein homolog 1N/A0.400.45C21orf33ES1 protein homolog, mitochondrialN/A0.450.49C9orf9Uncharacterized protein C9orf92.332.32N/ACABYRCalcium-binding tyrosine phosphorylation-regulated protein0.31N/AN/ACALRCalreticulin0.390.36N/ACCDC108Coiled-coil domain-containing protein 108N/AN/AN/ACCDC136Isoform 4 of Coiled-coil domain-containing protein 1362.632.93N/ACCDC147Coiled-coil domain-containing protein 1472.352.30N/ACOX4I1Cytochrome c oxidase subunit 4 isoform 1, mitochondrial1.991.60N/ACOX5BCytochrome c oxidase subunit 5B, mitochondrial2.602.34N/ACOX6B1Cytochrome c oxidase subunit 6B12.18N/AN/ACRISP2Cysteine-rich secretory protein 20.59N/AN/ACTSGCathepsin GN/A0.64N/ACYCSCytochrome c (Fragment)5.403.191.25CYLC2Cylicin-2N/A2.07N/ADNALI1Axonemal dynein light intermediate polypeptide 12.992.67N/ADPCDProtein DPCD0.450.44N/ADPEP3Dipeptidase 30.44N/AN/ADPY19L2Probable C-mannosyltransferase DPY19L26.525.44N/AELSPBP1Epididymal sperm-binding protein 14.955.02N/AFKBP1APeptidyl-prolyl cis--trans isomerase FKBP1A0.47N/AN/AFSCN3Fascin-34.633.88N/AFSIP2Fibrous sheath-interacting protein 22.171.99N/AGNPDA1Glucosamine-6-phosphate isomerase 1N/A0.33N/AHSF2BPHeat shock factor 2-binding protein2.28N/AN/AHSP90B1Endoplasmin0.290.37N/AHSPA2Heat shock-related 70 kDa protein 20.190.23N/AHSPA578 kDa glucose-regulated protein0.290.36N/AIMMTIsoform 4 of Mitochondrial inner membrane protein2.08N/AN/AKLHL10Kelch-like protein 100.430.50N/AKRT9Keratin, type I cytoskeletal 97.83N/AN/ALDHCL-lactate dehydrogenase C chain0.160.19N/AMNS1Meiosis-specific nuclear structural protein 1N/A0.48N/AMPC1LMitochondrial pyruvate carrier 1-like proteinN/A2.74N/AMRPS3628S ribosomal protein S36, mitochondrialN/A0.53N/ANAMPTNicotinamide phosphoribosyltransferase0.430.701.47NDUFA4NADH dehydrogenase \[ubiquinone\] 1 alpha subcomplex subunit 42.13N/AN/ANDUFS3NADH dehydrogenase \[ubiquinone\] iron-sulfur protein 3, mitochondrial1.67N/AN/ANUP62Nuclear pore glycoprotein p620.480.39N/AOAZ3Ornithine decarboxylase antizyme 32.833.14N/APAFAH1B3Platelet-activating factor acetylhydrolase IB subunit gammaN/A0.49N/APATE1Prostate and testis expressed protein 12.082.11N/APATE4Prostate and testis expressed protein 42.091.99N/APGAM2Phosphoglycerate mutase 20.450.33N/APGK1Phosphoglycerate kinase 10.400.56N/APGK2Phosphoglycerate kinase 20.340.38N/APHB2Prohibitin-21.99N/AN/APHGDHD-3-phosphoglycerate dehydrogenaseN/A2.20N/APMFBP1Isoform 2 of Polyamine-modulated factor 1-binding protein 14.383.82N/APPP4R1Serine/threonine-protein phosphatase 4 regulatory subunit 10.68N/AN/APRDX4Peroxiredoxin-4N/A0.41N/APREPProlyl endopeptidase0.57N/AN/APRKACAcAMP-dependent protein kinase catalytic subunit alpha0.430.44N/APRSS37Probable inactive serine protease 370.39N/AN/APRTN3MyeloblastinN/A0.66N/APSMA1Proteasome subunit alpha type-10.580.52N/APSMA2Proteasome subunit alpha type-20.320.31N/APSMA3Proteasome subunit alpha type-30.650.62N/APSMA4Proteasome subunit alpha type-40.400.38N/APSMA5Proteasome subunit alpha type-50.450.37N/APSMB1Proteasome subunit beta type-10.370.35N/APSMB4Proteasome subunit beta type-40.250.22N/APSMB5Proteasome subunit beta type-50.410.44N/APSMB7Proteasome subunit beta type-70.380.44N/ARAD23BUV excision repair protein RAD23 homolog B0.220.31N/ARDH16Retinol dehydrogenase 16N/A1.59N/AROPN1BRopporin-1B4.20N/AN/ARUVBL1RuvB-like 10.260.26N/ASEMG1Semenogelin-1N/A0.550.55SEPHS1Selenide, water dikinase 10.440.59N/ASEPT4Septin-41.73N/AN/ASLPIAntileukoproteinase4.90N/AN/ASMCPSperm mitochondrial-associated cysteine-rich proteinN/A3.08N/ASMRP1Spermatid-specific manchette-related protein 11.55N/AN/ASOD1Superoxide dismutase \[Cu--Zn\]0.140.17N/ASPA17Sperm surface protein Sp172.061.88N/ASPAG6Isoform 3 of Sperm-associated antigen 62.53N/AN/ASPANXA1Sperm protein associated with the nucleus on the X chromosome AN/A5.43N/ASPANXB1Sperm protein associated with the nucleus on the X chromosome B/F3.954.14N/ASPATA6Spermatogenesis-associated protein 63.98N/AN/ASPEM1Spermatid maturation protein 12.692.13N/ASPINT3Kunitz-type protease inhibitor 3N/A3.25N/ASTOMErythrocyte band 7 integral membrane proteinN/A0.50N/ATCP11T-complex protein 11 homolog2.06N/AN/ATEKT1Tektin-12.18N/AN/ATEKT2Tektin-24.352.861.16TEKT3Tektin-31.81N/AN/ATEKT4Tektin-42.132.05N/ATEKT5Tektin-5N/A2.32N/ATSGA10Testis-specific gene 10 protein10.589.59N/ATXNDC2Thioredoxin domain-containing protein 20.410.37N/AVAT1Synaptic vesicle membrane protein VAT-1 homolog0.600.64N/AVDAC3Voltage-dependent anion-selective channel protein 32.41N/AN/AWFDC8WAP four-disulfide core domain protein 83.122.39N/AZPBP1Zona pellucida-binding protein 1N/A0.41N/AZPBP2Zona pellucida-binding protein 20.420.54N/ACS/C, The fold of change between cryostraw (CS) and control (C); CV/C, The fold of change between cryovial (CV) and control (C); CV/CS, The fold of change between cryovial (CV) and cryostraw (CS)

Pathways analysis and protein interaction {#Sec15}
-----------------------------------------

The network of interactions of the differential identified proteins between C and CS groups is shown in Fig. [3](#Fig3){ref-type="fig"}a. Ten statistically enriched pathways were selected in the KEGG pathway (*p* \< 0.05), which include proteasome (20 proteins), carbon metabolism (20 proteins), biosynthesis of amino acids (13 proteins), glycolysis/gluconeogenesis (12 proteins), Parkinson's disease (16 proteins), Huntington's disease (17 proteins), Alzheimer's disease (14 proteins), protein processing in endoplasmic reticulum (16 proteins), metabolic pathways (57 proteins) and aminoacyl-tRNA biosynthesis (9 proteins).Fig. 3Protein interaction network. Protein interaction network of cryovial/control (**a**), cryovial/control (**b**), cryovial/cryostraw (**c**). 10 pathways were selected statistically enriched in the KEGG pathway (*p* \< 0.05). The dots in the figure represent the proteins, the red indicates the increased proteins, and the green represents the decreased proteins. The frame represents the KEGG process. The connection indicates that there is an interaction, the solid line is an interrelated relationship that has been reported, and the dotted line is an unconfirmed interaction

Similarly, the network of interactions of the differential identified proteins between C and CV groups is shown in Fig. [3](#Fig3){ref-type="fig"}b. Ten statistically selected pathways were enriched in the KEGG pathway (*p* \< 0.05), which include proteasome (19 proteins), carbon metabolism (22 proteins), biosynthesis of amino acids (15 proteins), glycolysis/gluconeogenesis (12 proteins), protein processing in endoplasmic reticulum (16 proteins), metabolic pathways (53 proteins), pentose phosphate pathway (5 proteins), citrate cycle (TCA cycle) (5 proteins), fructose and mannose metabolism (5 proteins) and renin-angiotensin system (4 proteins).

The network of interactions of the differential identified proteins between CV and CS groups is shown in Fig. [3](#Fig3){ref-type="fig"}c. Ten statistically enriched pathways were selected in the KEGG pathway (*p* \< 0.05), which includes Alzheimer's disease (7 proteins), Huntington's disease (7 proteins), Oxidative phosphorylation (6 proteins), Parkinson's disease (6 proteins), Metabolic pathways (11 proteins), Cardiac muscle contraction (3 proteins), Fructose and mannose metabolism (2 proteins), Non-alcoholic fatty liver disease (NAFLD) (3 proteins), Valine, leucine, and isoleucine biosynthesis (1 proteins) and Carbon metabolism (2 proteins).

Discussion {#Sec16}
==========

In the present study, we cryopreserved human sperm with an egg yolk-free medium and investigated the effects of cryopreservation using two different CPCs on the cryosurvival of sperm, evaluating motility parameters and the proteome profile of human sperm. After freezing and thawing, the motility parameters of sperm cryopreserved with either cryostraw or cryovial both decreased. However, the sperm cryopreserved in cryovials provided better cryoprotection on motility parameters of MOT and FAR than those preserved in cryostraws. The cryosurvival rate of CS group is consistent with the results reported in previous studies that human sperm cryopreserved in cryostraws showed a relative low cryosurvival rate when using commercial egg yolk free medium \[[@CR24]\]. The cooling rate is an important factor that affects the cryosurvival of cells \[[@CR32]\]. During freezing, ice nucleates initially in the extracellular spaces and causes an osmotic gradient between the freeze-concentrated extracellular solution and the intracellular solution. Cells are not dehydrated sufficiently when the cooling rate is too fast and intracellular ice formation leads to cryoinjuries in the cytoplasm. Conversely, when the cooling rate is too slow, cells are injured due to solution effects caused by severe dehydration and exposure to toxic concentrations of electrolytes \[[@CR19]\]. The optimal freezing rate for sperm cryosurvival should be low enough to avoid intracellular ice formation but fast enough to minimize solution effects \[[@CR23]\]. In our study, the sperm were frozen using protocols as suggested by the manufacturer of the sperm freezing medium. The cooling and warming rates of sperm in cryostraws and cryovials might be different during the freezing and thawing processes, which could be the reason that sperm cryopreserved in two CPCs with the same freezing medium showed different sperm cryosurvival rates and motility parameters. Therefore, the optimal cooling rate for human sperm cryopreservation still needs to be determined based on the freezing medium used.

Sperm cryopreservation plays an important role in clinical application of human fertility preservation and infertility treatment. Traditionally, sperm is diluted and equilibrated with commercial egg yolk free freezing medium and is loaded into different CPCs (usually cryostraw or cryovial) which are then frozen in liquid nitrogen vapors. So far, cryodamage is still a general and unavoidable phenomenon. A few studies have reported qualitative changes of protein profiles in fish \[[@CR25]\], ram \[[@CR27]\], boar \[[@CR29]\] and human sperm \[[@CR30]\] by proteome analysis, and demonstrated that cryopreservation may result in proteinic alteration of sperm, which is associated with sperm metabolism, membrane permeability, flagella structure and motility, apoptosis, intracellular signaling, capacitation and fertilization commonly \[[@CR22]\]. Proteinic alterations of human sperm at proteomic level caused by cryopreservation have been reported previously \[[@CR22], [@CR33]\]. Wang and colleagues identified 27 proteins that differed in abundance between fresh and frozen-thawed sperm. However, the proteomic analysis was performed by 2DE and image analysis. Furthermore, the sperm sample was cryopreserved with egg yolk buffered freezing medium containing 10% glycerol, which has been abandoned in clinical applications because egg yolk carries a risk of pathogen introduction into cryopreserved sperm samples. The development of higher throughput strategies for proteome study based on liquid chromatography and mass spectrometry allows detection of the proteinic alterations of sperm with high definition and precision. A previous study found that the abundance of human sperm proteins was altered after being cryopreserved in CV with a protein free medium named CryoSperm and was analyzed via LC--MS/MS. The authors indicated that fewer sperm proteinic changes occurred when semen was thawed in a 23 °C water bath and then maintained after-thawing at 0 °C (60 differential proteins detected) than when it was maintained after-thawing at 23 °C (99 differential proteins detected). In the present study, 139 increased proteins and 295 decreased proteins were detected in sperm cryopreserved with CV, and 115 increased proteins and 317 decreased proteins were detected in sperm cryopreserved with CS. There are several differences in this study as compared to the previous study. Firstly, a different protein-free commercial medium named Vitrolife's SpermFreeze Solution and freezing protocol were used in our study. Secondly, human semen samples were loaded into two different CPCs (cryostraws or cryovials) for cryopreservation, which are the most commonly used CPCs for human sperm cryopreservation. Lastly, semen samples were thawed in a 37 °C water bath, which is the common thawing method for sperm cryopreservation. These differences may contribute to the variation in proteins identified and quantified. The results also demonstrated that different sperm freezing media, freezing and thawing protocols or CPCs can lead to sperm proteomic profile variations. Cryoinjuries caused by intracellular ice formation lead to sublethal effects on sperm, and influences sperm motility and fertilizing ability \[[@CR34]\]. In the present study, the GO analysis revealed that the cellular localizations of the identified differential proteins of human sperm cryopreserved with either CS or CV were enriched in the extracellular membrane-bounded organelles, cytoplasm, and cytosol after cryopreservation. The results agree with previous studies that cryopreservation leads to the leakage of intracellular proteins \[[@CR35]\]. The disruption of the sperm membrane integrity resulting in the presence of sperm proteins in extracellular likely reflects damage of the sperm membrane structure \[[@CR28], [@CR36]\]. The identification of the biological processes of the identified differential proteins in human sperm cryopreserved with either CS or CV revealed that most of proteins are related to metabolic processes. Proteins of metabolic processes are responsible for the decrease in sperm metabolic activity caused by disturbances in ATP production and ATP regeneration resulting in the decline in sperm motility \[[@CR37]\]. Our results indicate that cryoinjuries damage sperm structures, but also decrease sperm metabolism. The latter can lead to a decline in sperm motility, life span, and fertilizing ability. Furthermore, the leakage of mitochondrial proteins from sperm after cryopreservation indicates that disruption of the mitochondrial structure could be responsible for the decrease in energy supply to sperm \[[@CR30]\]. Proteasomes can regulate sperm motility through regulation of dynein cAMP-dependent phosphorylation \[[@CR38]\]. In addition, the freezing--thawing process reduced the antioxidant capacity of human sperm \[[@CR39]\] and lead to disturbances in the ubiquitin--proteasome system, which possibly influenced the motility \[[@CR40]\].

Similar to previous studies, increased protein abundance in sperm cryopreserved either with CS or CV was observed \[[@CR22]\]. However, the mechanism remains unknown. It was believed that protein phosphorylation is a possible reason for the increased level of some proteins following cryopreservation, which leads to protein degradation, post-translational processing, and alterations in secondary or tertiary structure and/or translocation to other cellular compartments or outside the cell and results in changes in protein abundance \[[@CR22], [@CR33]\].

The identified differential proteins of human sperm cryopreserved with either CS or CV were categorized with UniProtKB database including spermatogenesis, spermatid development, flagellated sperm motility, sperm capacitation or acrosome reactions. Differences in the sperm function related proteins were observed between CS and CV groups, which indicate that even if the same freezing medium and the same freezing protocol were used, the effects on sperm proteome can be influenced by the CPCs applied. In addition, we also observed leakages of Ion channel proteins, especially Ca^2+^-binding proteins as shown in the Table [2](#Tab2){ref-type="table"} including HSPA5 (78 kDa glucose-regulated protein), CABYR (Calcium-binding tyrosine phosphorylation-regulated protein), HSP90B1 (Endoplasmin), CALR (Calreticulin). Calcium ions play a pivotal role in the mechanism controlling human sperm movement \[[@CR26], [@CR41]\]. Further studies are necessary to understand the significance of the disturbance to these proteins after cryopreservation with respect to the fertilizing ability of the sperm and embryo development. The network of interactions between the differentially identified proteins was analyzed. Interestingly, the KEGG pathways of Parkinson's disease, Huntington's disease, and Alzheimer's disease were observed in sperm cryopreserved with CS compared to control sperm, however, these results were not observed in sperm cryopreserved with CV. In consideration of the significantly higher value of MOT and FAR in sperm cryopreserved in CV group than CS group, the use of CV for human sperm cryopreservation in clinical application may provide better safety and efficiency.

Conclusion {#Sec17}
==========

In summary, human sperm motility parameters and proteomic profiles are greatly affected by cryopreservation with either type of CPC. GO analysis revealed that most of the differential sperm proteins identified with iTRAQ techniques were enriched in the extracellular membrane-bounded organelles, cytoplasm, and cytosol. In addition, 106 susceptible proteins having known identities in sperm functions were identified. These results provide useful information for insight into the cryoinjury mechanism and will be beneficial for the development and optimization of human sperm cryopreservation strategies.

Additional files
================
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**Additional file 1: Table S1.** Total of proteins were identified in human sperm. **Additional file 2: Table S2.** The differentially identified human sperm proteins.

CS

:   cryostraws

CV

:   cryovials

CPCs

:   cryopreservation carriers

iTRAQ

:   isobaric tags for relative and absolute quantification

ATP

:   adenosine triphosphate

WHO

:   World Health Organization

MOT

:   motile sperm

FAR

:   forward activity rate

VCL

:   curvilinear velocity

VSL

:   straight line velocity

VAP

:   average path velocity

LIN

:   linearity

STR

:   straightness index

VIB

:   vibration index

ALH

:   amplitude of lateral head displacement

TCA

:   trichloroacetic acid

FDR

:   false discovery rate

GO

:   gene ontology

NAFLD

:   non-alcoholic fatty liver disease
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